Recent Updates
Recently added Catalysts
NEO Positive Sentiment Score: 60/100

NeoGenomics Announces Settlement of Voluntary Disclosure to OIG-HHS

Key Takeaway: NeoGenomics has announced a settlement regarding its voluntary disclosure to the Office of Inspector General for Health and Human Services (OIG-HHS). This settlement reflects the company's efforts to address compliance matters proactively. The announcement highlights NeoGenomics' commitment to maintaining regulatory standards.
Price reaction · baseline $14.24 (2026-07-20 close) · hit after-hours · clean, no other NEO news in the window
day 0 close · peak
+1.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Settlement indicates a resolution to compliance issues.
  • Voluntary disclosure shows proactive approach by NeoGenomics.

Full Press Release Details

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics Announces Settlement of Voluntary Disclosure to OIG-HHS

Frequently Asked Questions

What did NeoGenomics announce recently?

NeoGenomics announced a settlement related to its voluntary disclosure to OIG-HHS.

What does the settlement indicate?

The settlement indicates a resolution to compliance issues faced by NeoGenomics.

What is OIG-HHS?

OIG-HHS stands for the Office of Inspector General for Health and Human Services.

Why is the settlement significant?

The settlement reflects NeoGenomics' proactive approach to addressing compliance matters.

Last updated: Jul 20, 2026